| scholarly article | Q13442814 |
| P2093 | author name string | Fioretti MC | |
| Bianchi R | |||
| Puccetti P | |||
| Uyttenhove C | |||
| Grohmann U | |||
| Vacca C | |||
| Fallarino F | |||
| Belladonna ML | |||
| Orabona C | |||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | dendritic cell | Q506253 |
| P304 | page(s) | 708-714 | |
| P577 | publication date | 2001-07-01 | |
| P1433 | published in | Journal of Immunology | Q3521441 |
| P1476 | title | IL-6 inhibits the tolerogenic function of CD8 alpha+ dendritic cells expressing indoleamine 2,3-dioxygenase | |
| P478 | volume | 167 |
| Q27863347 | 1-Methyl-tryptophan can interfere with TLR signaling in dendritic cells independently of IDO activity |
| Q36376640 | A defect in tryptophan catabolism impairs tolerance in nonobese diabetic mice |
| Q38195946 | Advances in the cellular immunological pathogenesis of type 1 diabetes |
| Q42710717 | Allergen-specific subcutaneous immunotherapy in allergic asthma: immunologic mechanisms and improvement |
| Q37039994 | Allostimulatory activity of bone marrow-derived plasmacytoid dendritic cells is independent of indoleamine dioxygenase but regulated by inducible costimulator ligand expression |
| Q38268639 | Aryl hydrocarbon receptor and kynurenine: recent advances in autoimmune disease research |
| Q45092706 | CD28 induces immunostimulatory signals in dendritic cells via CD80 and CD86. |
| Q36399304 | CTLA-4-Ig activates forkhead transcription factors and protects dendritic cells from oxidative stress in nonobese diabetic mice |
| Q44170968 | CTLA-4-Ig regulates tryptophan catabolism in vivo. |
| Q98291350 | Cancer Cell Metabolism Bolsters Immunotherapy Resistance by Promoting an Immunosuppressive Tumor Microenvironment |
| Q28484683 | Chimeric infectious bursal disease virus-like particles as potent vaccines for eradication of established HPV-16 E7-dependent tumors |
| Q34657500 | Chronic inflammation that facilitates tumor progression creates local immune suppression by inducing indoleamine 2,3 dioxygenase. |
| Q34657796 | Curcumin suppresses the induction of indoleamine 2,3-dioxygenase by blocking the Janus-activated kinase-protein kinase Cdelta-STAT1 signaling pathway in interferon-gamma-stimulated murine dendritic cells |
| Q37399728 | Cytokine treatment of macrophage suppression of T cell activation |
| Q36569018 | Dendritic cells and tumor microenvironment: a dangerous liaison |
| Q36899012 | Dendritic cells, indoleamine 2,3 dioxygenase and acquired immune privilege |
| Q36862971 | Dendritic cells: key to fetal tolerance? |
| Q46121081 | Disease Tolerance Mediated by Phosphorylated Indoleamine-2,3 Dioxygenase Confers Resistance to a Primary Fungal Pathogen |
| Q46737044 | Enhanced tryptophan catabolism in the absence of the molecular adapter DAP12. |
| Q37417083 | Expression and function of immunoglobulin-like transcripts on tolerogenic dendritic cells |
| Q39404674 | Expression and regulation of immune-modulatory enzyme indoleamine 2,3-dioxygenase (IDO) by human airway epithelial cells and its effect on T cell activation |
| Q44134414 | Expression of indoleamine 2,3-dioxygenase (IDO) by endothelial cells: implications for the control of alloresponses |
| Q55400645 | First-in-Human Phase I Study of the Oral Inhibitor of Indoleamine 2,3-Dioxygenase-1 Epacadostat (INCB024360) in Patients with Advanced Solid Malignancies. |
| Q37104636 | GM-CSF-induced CD11c+CD8a--dendritic cells facilitate Foxp3+ and IL-10+ regulatory T cell expansion resulting in suppression of autoimmune thyroiditis |
| Q36809755 | Harnessing the immune system to treat cancer |
| Q38682156 | Harnessing the properties of dendritic cells in the pursuit of immunological tolerance |
| Q35562495 | Hemopoietic Precursors and Development of Dendritic Cell Populations |
| Q94502750 | Hepatic Macrophages in Liver Injury |
| Q45163458 | High doses of CpG oligodeoxynucleotides stimulate a tolerogenic TLR9-TRIF pathway. |
| Q34674495 | IDO and regulatory T cells: a role for reverse signalling and non-canonical NF-kappaB activation |
| Q29614752 | IDO expression by dendritic cells: tolerance and tryptophan catabolism |
| Q36944802 | IDO-expressing regulatory dendritic cells in cancer and chronic infection |
| Q37129200 | IL-17 and therapeutic kynurenines in pathogenic inflammation to fungi |
| Q33968156 | IL-1β promotes TGF-β1 and IL-2 dependent Foxp3 expression in regulatory T cells. |
| Q64111913 | IL-35Ig-expressing dendritic cells induce tolerance via Arginase 1 |
| Q90568372 | Identification and characterisation of the CD40-ligand of Sigmodon hispidus |
| Q51722040 | Immune cells from patients with psoriasis are defective in inducing indoleamine 2,3-dioxygenase expression in response to inflammatory stimuli. |
| Q46458340 | Immune responses elicited by apoB-100-derived peptides in mice. |
| Q36256306 | Immunoregulation of dendritic cells |
| Q42575748 | Indolamine 2,3-dioxygenase regulation and neuropsychiatric symptoms. |
| Q46393442 | Indoleamine 2, 3-dioxygenase (IDO) is essential for dendritic cell activation and chemotactic responsiveness to chemokines |
| Q36809762 | Indoleamine 2,3-dioxygenase and tumor-induced tolerance |
| Q34973801 | Indoleamine 2,3-dioxygenase, immunosuppression and pregnancy |
| Q35131219 | Indoleamine 2,3-dioxygenase-expressing dendritic cells form suppurative granulomas following Listeria monocytogenes infection |
| Q51597260 | Indoleamine 2,3-dioxygenase-expressing peripheral cells in rheumatoid arthritis and systemic lupus erythematosus: a cross-sectional study. |
| Q37301247 | Indoleamine 2,3-dioxygenase: expressing cells in inflammatory bowel disease-a cross-sectional study. |
| Q38032201 | Indoleamine 2,3-dioxygenase: from catalyst to signaling function |
| Q89927611 | Inhibition of IDO leads to IL-6-dependent systemic inflammation in mice when combined with photodynamic therapy |
| Q36376598 | Inhibition of allogeneic T cell proliferation by indoleamine 2,3-dioxygenase-expressing dendritic cells: mediation of suppression by tryptophan metabolites |
| Q45150486 | Inhibition of allogeneic T-cell responses by dendritic cells expressing transduced indoleamine 2,3-dioxygenase |
| Q28610462 | Is the CD200/CD200 receptor interaction more than just a myeloid cell inhibitory signal? |
| Q58843506 | Kinetics of regulatory dendritic cells in inflammatory responses during Trypanosoma evansi infection |
| Q36154801 | Live-attenuated lentivirus immunization modulates innate immunity and inflammation while protecting rhesus macaques from vaginal simian immunodeficiency virus challenge. |
| Q48123228 | Loss of CNFY toxin-induced inflammation drives Yersinia pseudotuberculosis into persistency. |
| Q37010267 | Mechanism of T cell tolerance induction by murine hepatic Kupffer cells |
| Q54256455 | Mechanisms of Tolerance Induction by Dendritic Cells In Vivo. |
| Q36632492 | Modulation of invariant natural killer T cell cytokine responses by indoleamine 2,3-dioxygenase |
| Q44632333 | Modulation of tryptophan catabolism by regulatory T cells. |
| Q34576401 | Mouse and human dendritic cell subtypes |
| Q39924299 | Non-transmissible Sendai virus encoding granulocyte macrophage colony-stimulating factor is a novel and potent vector system for producing autologous tumor vaccines |
| Q37809070 | Novel findings in drug-induced dendritic cell tolerogenicity |
| Q43205815 | Novel role of plasmacytoid dendritic cells in humans: induction of interleukin-10-producing Treg cells by plasmacytoid dendritic cells in patients with rheumatoid arthritis responding to therapy |
| Q38450454 | Pattern of recruitment of immunoregulatory antigen-presenting cells in malignant melanoma. |
| Q35366959 | Proteasomal Degradation of Indoleamine 2,3-Dioxygenase in CD8 Dendritic Cells is Mediated by Suppressor of Cytokine Signaling 3 (SOCS3) |
| Q36079905 | Regulatory T cells and autoimmune disease |
| Q41867403 | Repeated social defeat activates dendritic cells and enhances Toll-like receptor dependent cytokine secretion |
| Q54732704 | Reverse signaling using an inducible costimulator to enhance immunogenic function of dendritic cells. |
| Q34554298 | Role of regulatory dendritic cells in allergy and asthma |
| Q37081582 | SOCS3 drives proteasomal degradation of indoleamine 2,3-dioxygenase (IDO) and antagonizes IDO-dependent tolerogenesis |
| Q44137068 | T cell apoptosis by tryptophan catabolism |
| Q37334065 | T cell regulatory plasmacytoid dendritic cells expressing indoleamine 2,3 dioxygenase |
| Q37002795 | T-cell death and cancer immune tolerance |
| Q38110540 | Targeting Tregs in Malignant Brain Cancer: Overcoming IDO. |
| Q37352554 | Targeting the immunoregulatory indoleamine 2,3 dioxygenase pathway in immunotherapy |
| Q47714445 | The cryo-thermal therapy-induced IL-6-rich acute pro-inflammatory response promoted DCs phenotypic maturation as the prerequisite to CD4+ T cell differentiation |
| Q34657284 | The indoleamine 2,3-dioxygenase pathway is essential for human plasmacytoid dendritic cell-induced adaptive T regulatory cell generation |
| Q35603220 | The role of pDC, recipient T(reg) and donor T(reg) in HSC engraftment: Mechanisms of facilitation |
| Q77218151 | The same immunoregulatory molecules contribute to successful pregnancy and transplantation |
| Q63441884 | Therapy with dendritic cells influences the spontaneous resorption rate in the CBA/J x DBA/2J mouse model |
| Q49592866 | Tryptophan Catabolism and Cancer Immunotherapy Targeting IDO Mediated Immune Suppression. |
Search more.